Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01413555 · ClinicalTrials.gov registry record · NA
Multicenter Blood Culture Quality Improvement
A NA study of Bacteremia, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 14,889
- Enrollment target
- 2
- Study locations
NCT01413555: Completed NA study of Bacteremia, sponsored by Vanderbilt University.
NCT01413555 is a NA study of Bacteremia that has completed, run by Vanderbilt University. The registered enrollment target is 14,889 participants, above the 6,223-participant average among 11 other Bacteremia trials with a reported enrollment target (139% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01413555, a NA study of Bacteremia, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14,889 participants
- Enrollment target
- 2
- Study locations
Study Summary
False positive blood culture results due to specimen contamination with bacteria inhabiting patients' skin is a common problem in emergency departments (EDs) in the United States. Contaminated blood cultures lead to patient harm through unnecessary hospitalizations and ED visits, delays in surgery, unneeded antibiotics, and unnecessary procedures. The investigators have developed a multifaceted quality improvement improvement bundle (The Blood Culture QI Program) designed to minimize blood culture contamination in the ED. In this study, the investigators will implement the quality improvement bundle in six community hospital EDs and evaluate its effectiveness at reducing contamination.
Primary Outcome
In an interrupted time series design, we will compare the proportion of blood cultures contaminated during an intervention period after the implementation of the Blood Culture QI Program to a baseline period before implementation. We will complete six separate interrupted time series analyses with one at each of six hospitals. The intervention and baseline period duration will be approximately one year at each hospital.
Conditions Studied
Interventions
- OTHER Blood Culture QI Program
Study Locations (2)
Tennessee
- Vanderbilt Emergency Medicine - Nashville
- Vanderbilt University Medical Center Emergency Medicine - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,889 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01413555 record still lists
NCT01413555 is an interventional study that assigns participants to a tested intervention. Its 14,889 participants enrollment target places it among the larger protocols in the corpus, above the 6,223-participant average among 11 other Bacteremia trials with a reported enrollment target (139% higher).
The record links to 1 condition, with Bacteremia appearing as the primary indexed condition, and to 1 intervention - of which Blood Culture QI Program is the first listed.
NCT01413555 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01413555 about?
NCT01413555 is a clinical study titled "Multicenter Blood Culture Quality Improvement". False positive blood culture results due to specimen contamination with bacteria inhabiting patients' skin is a common problem in emergency departments (EDs) in the United States. Contaminated blood cultures lead to patient harm through unnecessary hospitalizations and ED visits, delays in surgery, ...
What is the current status of trial NCT01413555?
This trial is currently completed. It is a NA study. The enrollment target is 14,889 participants. The study started on 2011-08. Estimated completion is 2013-03.
What conditions does trial NCT01413555 study?
This clinical trial studies the following conditions: Bacteremia.
What interventions are being tested in trial NCT01413555?
The interventions under investigation include: Blood Culture QI Program (OTHER).
Who is sponsoring clinical trial NCT01413555?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01413555 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacteremia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01413555's enrollment target sits among peer trials
14,889 2nd of 11 the highest of 11 other Bacteremia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacteremia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reducing Risk for Infective Endocarditis
RECRUITING · NA
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
COMPLETED · NA
-
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
RECRUITING
-
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
ACTIVE NOT RECRUITING
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
COMPLETED
-
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia